SCHEMBL29369652

SCHEMBL29369652

O=C(c1ccccc1)C(c1ccccc1)C1CCCCO1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 8/20 0.67
L3MBTL1 Q9Y468 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41
HTR1E P28566 1/20 0.41
KMT2A Q03164 1/20 0.41
S1PR3 Q99500 1/20 0.41
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
ALDH1A1 P00352 2/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
MITF O75030 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15846301 0.85 SLC6A3 (0.70) SLC6A3LMNAMEN1MAPTHTR1E
SCHEMBL28779591 0.83 SLC6A3 (0.52) SLC6A3L3MBTL1LMNAMEN1KMT2A
SCHEMBL14198963 0.81 TDP1 (0.50) SLC6A3L3MBTL1TDP1LMNAMEN1
SCHEMBL31372474 0.81 SLC6A3 (0.53) SLC6A3LMNAMEN1KMT2AGAA
SCHEMBL27759418 0.81 SLC6A3 (0.50) SLC6A3L3MBTL1LMNAMEN1KMT2A
SCHEMBL29374096 0.79 SLC6A3 (0.56) SLC6A3LMNAMEN1MAPTHTR1E
SCHEMBL27784471 0.78 SLC6A3 (0.47) SLC6A3L3MBTL1LMNAMEN1KMT2A
SCHEMBL27759419 0.76 KMT2A (0.47) SLC6A3L3MBTL1LMNAMEN1KMT2A
SCHEMBL31618596 0.74 SLC6A3 (0.56) SLC6A3L3MBTL1TDP1LMNAMEN1
SCHEMBL4566341 0.74 SLC6A3 (0.50) SLC6A3MEN1KMT2AHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115003783-B Improvement of by-product of waste oil regeneration process 伊特利姆再生公司 2023-07-28 CN claimed
CN-115069277-B Catalyst for low-temperature removal of siloxane in VOCs and preparation method thereof 深圳市捷晶科技股份有限公司 2024-05-17 CN disclosed
US-11739184-B2 Polysiloxazane compound having alkoxysilyl group, process for producing same, and composition and cured product including same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-08-29 US disclosed
CN-115003783-B Improvement of by-product of waste oil regeneration process 伊特利姆再生公司 2023-07-28 CN disclosed
CN-115003783-B Improvement of by-product of waste oil regeneration process 伊特利姆再生公司 2023-07-28 CN disclosed
US-11708460-B2 Alkoxysilyl group-containing organic silazane compound, method for producing same, composition containing same and cured product SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-07-25 US disclosed
CN-111484621-B Polysilosilazane compound, method for preparing the same, composition comprising the same, and cured product thereof 信越化学工业株式会社 2023-06-20 CN disclosed
EP-3798252-B1 POLYSILOXAZANE COMPOUND HAVING ALKOXYSILYL GROUP, PROCESS FOR PRODUCING SAME, AND COMPOSITION AND CURED PRODUCT INCLUDING SAME SHINETSU CHEMICAL CO (JP) 2022-06-29 EP disclosed
US-11339252-B2 Polysiloxazane compound, method for producing the same, and composition containing the same and cured product thereof SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-05-24 US disclosed
US-11236001-B2 Hydrothermal treatment device, biomass fuel manufacturing plant, hydrothermal treatment method, and biomass fuel manufacturing method MITSUBISHI POWER, LTD. (JP) 2022-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11708460-B2 Alkoxysilyl group-containing organic silazane compound, method for producing same, composition containing same and cured product OR10J3, ALKBH1, ALKBH2 SLC6A3 4706/4885L3MBTL1 1367/4885TDP1 3926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.